Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02716415Phase 4Completed
Phase 4, randomised, single-blind trial of Calmoseptine in diaper dermatitis, sponsored by University of the Philippines. Primary endpoint: Healing of Diaper Dermatitis at 6 days. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02716415.